Dyslipidaemia [dsyn]
Type 2 Diabetes [dsyn]
pathophysiology [ftcn]
Management [ocac]
Dyslipidaemia [dsyn]
risk factors [qnco]
Cardiovascular disease [dsyn]
Diabetes Mellitus [dsyn]
Mount [medd]
Clinical Data [inpr]
Trial [resa]
Management [ocac]
Dyslipidaemia [dsyn]
lowering [spco]
Low Density Lipoprotein Cholesterol [bacs, strd]
Continue [idcn]
controversies [socb]
diabetic [fndg]
Dyslipidaemia [dsyn]
plasma concentration [qnco]
Triglyceride [bacs, lipd]
Reduced [qlco]
High Density Lipoprotein Cholesterol [bacs, lipd]
Concentration [menp]
Increased [qnco]
Concentration [menp]
Small [qnco]
Dense [qlco]
LDL particle [celc]
Increased [qnco]
free fatty acid [lipd]
Flux [npop]
secondary [neop]
Insulin Resistance [patf]
Aggravated [fndg]
Increased [qnco]
Inflammatory [ftcn]
Adipokines [aapp, bacs]
Availability [ftcn]
Several [qnco]
Lipid lowering drug [phsu]
nutritional supplements [food]
Novel [tmco]
effective [qlco]
Options [ftcn]
Target [ftcn]
Lipid level [lbtr]
People [popg]
Diabetes [dsyn]
Initiation [menp]
Drug Therapy [topp]
Based [ftcn]
Lipid [lipd]
Profile [lbpr]
Option [ftcn]
practice guidelines [inpr]
recommend [idcn]
Statins [orch, phsu]
First-Line Therapy [topp]
utility [orgt]
Combination [qlco]
Statins [orch, phsu]
Fibrates [orch, phsu]
Nicotinic Acid [orch, phsu, vita]
Reducing [qlco]
cardiovascular events [fndg]
Inconclusive [idcn]
Suggest [idcn]
subgroup [virs]
high triglycerides [fndg]
Low density lipoprotein cholesterol level [lbpr]
Benefit [qnco]
Combination Therapy [topp]
Statins [orch, phsu]
Fibrates [orch, phsu]
Goal [inpr]
therapy [ftcn]
reduction [npop]
Low density lipoprotein cholesterol level [lbpr]
Low Density Lipoprotein Cholesterol [bacs, strd]
mg dl [qnco]
Low Risk [fndg]
People [popg]
mg dl [qnco]
At risk [qlco]
Including [ftcn]
People [popg]
Established [qlco]
Cardiovascular disease [dsyn]
